Table 2. Comorbidities.

	Comorbidities*		Total (N = 240) n (%)
	Mental health	Depression	42 (18%)
		Anxiety / panic disorder	28 (12%)
		Bipolar disorder	16 (7%)
		Attention-deficit/hyperactivity disorder (ADHD)	12 (5%)
		Schizophrenia / psychosis / hallucinations	10 (4%)
		Post-traumatic stress disorder (PTSD)	9 (4%)
		Other mental health conditions	13 (5%)
	Chronic pain	Chronic pain	48 (20%)
	Neurologic	Seizure disorder	7 (3%)
		Brain injury	6 (2%)
		Stroke	5 (2%)
		Other neurologic conditions	9 (4%)
	Pulmonary / respiratory	Asthma	29 (12%)
		Chronic obstructive pulmonary disease (COPD)	13 (5%)
		Other pulmonary respiratory conditions	4 (2%)
	Cardiovascular	Hypertension	22 (9%)
		Thrombosis (e.g., deep vein thrombosis, pulmonary embolism)	13 (5%)
		Congestive heart failure	9 (4%)
		Valvular conditions	7 (3%)
		Arrhythmias	6 (2%)
		Dyslipidemia	5 (2%)
		Other cardiovascular conditions	14 (6%)
	Gastrointestinal	Gastroesophageal reflux disease (GERD)	12 (5%)
		Ulcer	8 (3%)
		Other gastrointestinal conditions	16 (7%)
	Metabolic / endocrine	Diabetes (type 1, type 2 or unspecified)	11 (5%)
		Other metabolic / endocrine conditions	9 (4%)
	Renal	Renal failure or dysfunction	5 (2%)
		Other renal conditions	5 (2%)
	Musculoskeletal / rheumatologic	Arthritis	12 (5%)
		Systemic inflammatory conditions	5 (2%)
		Other musculoskeletal / rheumatologic	15 (6%)
	Hematologic / oncologic	Anemia	12 (5%)
		Other hematological or oncological conditions	7 (3%)
	Comorbidity count/patient, median (range)		1 (0–11)

*Could have more than one comorbidity.